Amanin

Amanin contains a cyclic peptide architecture featuring tightly constrained backbone geometry. Its noncanonical residues contribute to structural rigidity and resistance to unfolding. Researchers explore its molecular-recognition properties and conformational stability. Applications include toxin-analogue modeling, structural biology, and constrained-peptide research.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Amanin(CAS 21150-21-0)

CAT No: R2683

CAS No:21150-21-0

Synonyms/Alias:AMANIN;Amanine;UNII-VIW95I76GY;VIW95I76GY;21150-21-0;HSDB 3457;DTXSID70895849;BRN 1070214;alpha-Amanitin, 1-L-aspartic acid-4-(2-mercapto-L-tryptophan)-;9,18-(Iminoethaniminoethaniminoethaniminomethano)pyrrolo(1',2':8, 9)(1,5,8,11,14)thiatetraaza cyclooctadecino(18,17-b)indole-6-acetic acid, 1,2,3,5,6,7,8,9,10,12,17,18,19,20,21,22,23,23a-octadecahydro-29-sec-butyl-21-(2,3-dihydroxy-1-methylpropyl)-2-hydroxy-5,8,20,23,24,27,30,33-octaoxo-, 11-oxide;9,18-(Iminoethaniminoethaniminoethaniminomethano)pyrrolo(1',2':8,9)(1,5,8,11,14)thiatetraazacyclooctadecino(18,17-b)indole-6-acetic acid, 1,2,3,5,6,7,8,9,10,12,17,18,19,20,21,22,23,23a-octadecahydro-29-sec-butyl-21-(2,3-dihydroxy-1-methylpropyl)-2-hydroxy-5,8,20,23,24,27,30,33-octaoxo-, 11-oxide;2-((1S,4S,8R,10S,13S,16S,34S)-34-((2S)-butan-2-yl)-13-((2R,3R)-3,4-dihydroxybutan-2-yl)-8-hydroxy-2,5,11,14,27,30,33,36,39-nonaoxo-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo(14.12.11.06,10.018,26.019,24)nonatriaconta-18(26),19,21,23-tetraen-4-yl)acetic acid;2-(34-(butan-2-yl)-8,22-dihydroxy-13-(3-hydroxybutan-2-yl)-2,5,11,14,27,30,33,36,39-nonaoxo-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonaazapentacyclo(14.12.11.06,10.018,26.019,24)nonatriaconta-18(26),19,21,23-tetraen-4-yl)acetic acid;2-[(1S,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8-hydroxy-2,5,11,14,27,30,33,36,39-nonaoxo-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19,21,23-tetraen-4-yl]acetic acid;2-[34-(butan-2-yl)-8,22-dihydroxy-13-(3-hydroxybutan-2-yl)-2,5,11,14,27,30,33,36,39-nonaoxo-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonaazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19,21,23-tetraen-4-yl]acetic acid;.ALPHA.-AMANITIN, 1-L-ASPARTIC ACID-4-(2-MERCAPTO-L-TRYPTOPHAN)-;DTXCID801325348;CYCLO(L-.ALPHA.-ASPARTYL-4-HYDROXY-L-PROLYL-(R)-4,5-DIHYDROXY-L-ISOLEUCYL-2-MERCAPTO-L-TRYPTOPHYLGLYCYL-L-ISOLEUCYLGLYCYL-L-CYSTEINYL) CYCLIC (4->8)-SULFIDE (R)-S-OXIDE;alphaAmanitin, 1Laspartic acid4(2mercaptoLtryptophan);1-L-aspartic acid-4-(2-mercapto-L-tryptophan)-alpha-amanitin;9,18 (Iminoethaniminoethaniminoethaniminomethano)pyrrolo(1',2':8, 9)(1,5,8,11,14)thiatetraaza cyclooctadecino(18,17b)indole 6acetic acid, 1,2,3,5,6,7,8,9,10,12,17,18,19,20,21,22,23,23aoctadecahydro29secbutyl21(2,3dihydroxy1methylpropyl)2hydroxy5,8,20,23,24,27,30,33octaoxo, 11oxide;CYCLO(L-ALPHA-ASPARTYL-4-HYDROXY-L-PROLYL-(R)-4,5-DIHYDROXY-L-ISOLEUCYL-2-MERCAPTO-L-TRYPTOPHYLGLYCYL-L-ISOLEUCYLGLYCYL-L-CYSTEINYL) CYCLIC (4->8)-SULFIDE (R)-S-OXIDE;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C39H53N9O14S
M.W/Mr.
904

Amanin, also known as α-amanitin, is a potent bicyclic octapeptide toxin primarily derived from the Amanita phalloides mushroom. This compound is renowned for its remarkable stability and resistance to heat and enzymatic degradation, making it a valuable tool in molecular biology and biochemical research. Amanin's unique structure allows it to interact specifically with cellular machinery, particularly RNA polymerases, which are essential for gene transcription. Its ability to selectively inhibit these enzymes has paved the way for diverse scientific applications, ranging from fundamental studies of gene expression to innovative biotechnological techniques. The compound's specificity and well-characterized mechanism of action have made it a staple in laboratories investigating the intricacies of cellular transcription and the regulation of genetic information.

Gene Transcription Studies: Amanin is widely employed in the study of gene transcription due to its high affinity for eukaryotic RNA polymerase II. By binding to this enzyme, it effectively halts the transcription of DNA into messenger RNA, enabling researchers to dissect the steps involved in gene expression and to distinguish between RNA polymerase II-dependent and -independent processes. This targeted inhibition provides a precise tool for mapping transcriptional pathways and identifying the roles of specific genes in various cellular contexts, contributing to a deeper understanding of genetic regulation and cellular function.

RNA Polymerase Mechanism Elucidation: The use of α-amanitin in elucidating the structure and function of RNA polymerases has been instrumental in advancing molecular biology. By introducing the compound into in vitro or cell-based assays, scientists can observe the effects of polymerase inhibition on transcriptional dynamics, allowing for the identification of crucial enzyme subunits and functional domains. Such studies have clarified the mechanisms by which RNA polymerases recognize, bind, and transcribe DNA templates, and have facilitated the development of novel inhibitors with improved selectivity or altered activity profiles.

Cellular Toxicity and Apoptosis Research: Amanin's capacity to disrupt essential cellular processes makes it a valuable model compound for examining the pathways leading to cell death and apoptosis. When introduced to cultured cells, it triggers a cascade of molecular events that culminate in programmed cell death, providing a controlled system for investigating the molecular triggers and signaling networks underlying apoptosis. Researchers use these insights to better understand cellular responses to stress and to identify potential therapeutic targets for diseases characterized by aberrant cell survival or death.

Development of Antibody-Drug Conjugates: The unique cytotoxic properties of α-amanitin have inspired its use in the development of antibody-drug conjugates (ADCs) for targeted cell ablation in preclinical models. By chemically linking amanin to antibodies that recognize specific cell surface markers, scientists can direct its potent inhibitory activity toward defined cell populations, such as cancer cells or other pathological cell types. This approach enables the selective elimination of undesirable cells while minimizing off-target effects, and has become a valuable strategy in the exploration of targeted therapies and precision medicine.

Molecular Probe for Enzyme Inhibition Assays: In biochemical research, amanin serves as a molecular probe for screening and characterizing inhibitors of RNA polymerase II. Its well-documented inhibitory profile allows for the calibration of assay systems and the validation of new small molecule inhibitors. By comparing the effects of candidate compounds to those of amanin, researchers can accurately assess potency, selectivity, and mechanism of action, facilitating the discovery and optimization of novel transcriptional modulators for research and therapeutic purposes.

Protein Synthesis Inhibition Models: In addition to its primary action on transcription, amanin is sometimes utilized as a reference compound in studies exploring the interplay between transcriptional and translational control. By inhibiting mRNA synthesis, it indirectly affects downstream protein production, providing a useful model for dissecting the consequences of impaired gene expression on cellular physiology. These studies enhance our understanding of the integrated regulation of gene expression and the cellular adaptations that occur in response to transcriptional blockade, informing broader research in molecular and cellular biology.

InChI
InChI=1S/C39H53N9O14S/c1-4-17(2)31-36(59)41-12-28(52)42-25-16-63(62)38-21(20-7-5-6-8-22(20)45-38)10-23(33(56)40-13-29(53)46-31)43-37(60)32(18(3)27(51)15-49)47-35(58)26-9-19(50)14-48(26)39(61)24(11-30(54)55)44-34(25)57/h5-8,17-19,23-27,31-32,45,49-51H,4,9-16H2,1-3H3,(H,40,56)(H,41,59)(H,42,52)(H,43,60)(H,44,57)(H,46,53)(H,47,58)(H,54,55)/t17-,18-,19+,23-,24-,25+,26-,27-,31-,32-,63?/m0/s1
InChI Key
QCZXQEYEVLCQHL-OEPUBGLGSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Epitope Mapping ServicesPeptide Analysis ServicesPeptide CDMOCustom Conjugation ServicePeptide Synthesis ServicesPeptide Modification ServicescGMP Peptide ServicePeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers